Research and Markets: Antibody Sourcing and Usage Survey - Understanding the Future Needs of Scientists

Research and Markets ( has announced the addition of the "Antibody Sourcing and Usage Survey" report to their offering.

The core focus of this survey was to better understand the current and future needs of the community of scientists that rely on research grade antibodies for their experiments into key areas of human health and disease.

The survey of 400 life scientists reveals that research antibodies remain a hot commodity, with 94 percent of respondents planning to maintain or increase their current antibody usage in the next year.

“The data suggests a real growth trend in the $2 billion a year research antibody market,” says Alex Hodgson, CEO, 1DegreeBio. “However, the ways in which antibodies are used and sourced are changing. Companies need to be aware and ready to evolve.”

While some learning could be categorized as more confirmations, others proved to uncover valuable insights.

- Social media has become a strong vehicle with only 3% of respondents not participating on one of the four leading social media platforms (Facebook, LinkedIn, Google+ and Twitter). Google+, though being the most recently launched platform, edged out Twitter in our survey.

- 94% of respondents stated that they would maintain or increase their antibody usage levels in

the next 12 months.

- Of participants who plan to increase their antibody usage in the next 12 months, 53% will be adding 1-2 antibody-based applications each week.

- Multiple channels are used for product sourcing with varying types of peer review (journals and user reviews) continuing to be significant impact. Supplier websites are a key tool in the process, but they are rarely used on their own.

- Our respondents learn of new products through visiting supplier websites, sales representatives and direct email campaigns. This suggests that existing customers - or those familiar with the brand - are the first target market. As these customers use the product, they pave the way for wider markets through the publication of research data and recommendations that attract general users.

- 48% of respondents felt that up to 50% of the products they have used are of insufficient quality.

Though some may question the validity of perception-based questions, the takeaway for market stakeholders is that almost 50% of antibody users do not have confidence in these products. - 30% of our survey participants are currently considering the use of outside service providers to assist with their antibody-based research with particular focus around monoclonal facilities and providers.

Key Topics Covered:











Companies Mentioned

- Abbiotec

- Abcam

- Abchem

- BioLegend

- BioSupply UK

- BioVectra Inc

- Cedarlane

- Covance

- Dako

- FabGennix

- GE Healthcare

- GeneTex

- Gibco

- Neoclone

- Novus Biologicals

- Peprotech Inc.

- Precision Antibody

- Qiagen

- Thermo-Fisher

- U.S. Biologicals

- Zymed

- eBioscience

For more information visit


Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology, Pharmaceuticals
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here